The patient should be given anti-platelet aggregation for recurrent episodes of transient cerebral ischemia, which can be single-combination anti-platelet aggregation or double-combination anti-platelet aggregation, which is determined by abcd score according to the patient’s clinical symptoms. The duration of antiplatelet aggregation treatment should be determined by the patient’s score of 1 week or 21 days. Patients with severe vascular stenosis are recommended to extend the duration of duplex antiplatelet aggregation appropriately, and at the same time, patients should be given medication to improve circulation and blood circulation, such as sedation of Ginkgo biloba preparation, Shuxuetong, injectable thromboxane, Danhong injection, etc. If necessary, volume expansion treatment should be carried out, such as sedation of hydroxyethyl amylase. At the same time, the risk factors of cerebrovascular atherosclerosis should be investigated, and blood pressure, blood sugar and serum homocysteine should be actively controlled, and symptomatic treatment such as stenting can be carried out if the patient’s vascular stenosis is heavy.